Feature|Articles|August 13, 2026
- Pharmaceutical Executive: August 2026
- Volume 46
- Issue 6
2026 Emerging Pharma Leaders
Author(s)Mike Hollan
Listen
0:00 / 0:00
From guiding pursuits in artificial intelligence and R&D to scientific marketing and company building, meet Pharm Exec’s new slate of select rising leaders who are helping to shape the next generation of biopharma innovation.
Advertisement
Follow the links below to read about each selection:
(In alphabetical order)
* These five selections were chosen from a pool of nominations evaluated by the Pharmaceutical Executive Editorial staff. Selections were based on a number of criteria and review of professional accomplishments and progression of responsibilities in line with those executives inhabiting key “C-suite” functions.
Articles in this issue
about 1 hour ago
Making the Smart Career Movesabout 1 hour ago
Two Decades of Technology Transformation in Pharmaabout 1 hour ago
Finding the Universal Truth in a Drug's Storyabout 1 hour ago
What C-Suite Readiness Really RequiresAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Taking a Hard Look at Pharma's Traditional Margin Model
2
The Current Status of the 340B Program
3
Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics
4
Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing
5